266 related articles for article (PubMed ID: 11406560)
61. Cell detachment triggers p38 mitogen-activated protein kinase-dependent overexpression of Fas ligand. A novel mechanism of Anoikis of intestinal epithelial cells.
Rosen K; Shi W; Calabretta B; Filmus J
J Biol Chem; 2002 Nov; 277(48):46123-30. PubMed ID: 12356751
[TBL] [Abstract][Full Text] [Related]
62. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
Yu X; Liu L; Cai B; He Y; Wan X
Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
[TBL] [Abstract][Full Text] [Related]
63. Anoikis is regulated by BCL-2-independent pathways in human prostate carcinoma cells.
Bondar VM; McConkey DJ
Prostate; 2002 Apr; 51(1):42-9. PubMed ID: 11920957
[TBL] [Abstract][Full Text] [Related]
64. Resistance to p53-mediated growth suppression in human ovarian cancer cells retain endogenous wild-type p53.
Jin X; Burke W; Rothman K; Lin J
Anticancer Res; 2002; 22(2A):659-64. PubMed ID: 12014634
[TBL] [Abstract][Full Text] [Related]
65. Artonin E mediates MCL1 down-regulation and sensitizes lung cancer cells to anoikis.
Wongpankam E; Chunhacha P; Pongrakhananon V; Sritularak B; Chanvorachote P
Anticancer Res; 2012 Dec; 32(12):5343-51. PubMed ID: 23225436
[TBL] [Abstract][Full Text] [Related]
66. Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2 cM fragment in chromosomal region 6q24-q25.
Wan M; Sun T; Vyas R; Zheng J; Granada E; Dubeau L
Oncogene; 1999 Feb; 18(8):1545-51. PubMed ID: 10102624
[TBL] [Abstract][Full Text] [Related]
67. Assessment of resistance to anoikis in ovarian cancer.
He X; Chien J; Shridhar V
Methods Mol Biol; 2013; 1049():347-54. PubMed ID: 23913229
[TBL] [Abstract][Full Text] [Related]
68. Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death.
Coates JM; Galante JM; Bold RJ
J Surg Res; 2010 Dec; 164(2):301-8. PubMed ID: 20031162
[TBL] [Abstract][Full Text] [Related]
69. Microarray proteomic analysis discriminates tumorigenic mouse ovarian surface epithelial cells of divergent aggressive potential.
Urzúa U; Best L; Munroe DJ
Mol Biosyst; 2010 Dec; 6(12):2521-8. PubMed ID: 20938528
[TBL] [Abstract][Full Text] [Related]
70. The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma.
Tan M; Asad M; Heong V; Wong MK; Tan TZ; Ye J; Kuay KT; Thiery JP; Scott C; Huang RY
Mol Oncol; 2019 Apr; 13(4):757-780. PubMed ID: 30548372
[TBL] [Abstract][Full Text] [Related]
71. Effects of tetracycline-controlled antisense bcl-2 expression on the growth and apoptosis of human neuroblastoma cell line SK-N-MC.
Guan J; Chen J; Zhao H
Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):135-9. PubMed ID: 12419161
[TBL] [Abstract][Full Text] [Related]
72. Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression.
Yan L; Wang C; Lin B; Liu J; Liu D; Hou R; Wang Y; Gao L; Zhang S; Iwamori M
Biochimie; 2015 Jun; 113():17-25. PubMed ID: 25726913
[TBL] [Abstract][Full Text] [Related]
73. ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells.
Khan IA; Yoo BH; Masson O; Baron S; Corkery D; Dellaire G; Attardi LD; Rosen KV
Oncogene; 2016 Nov; 35(44):5759-5769. PubMed ID: 27109096
[TBL] [Abstract][Full Text] [Related]
74. Human ovarian carcinoma cells maintained on extracellular matrix versus plastic.
Crickard K; Crickard U; Yoonessi M
Cancer Res; 1983 Jun; 43(6):2762-7. PubMed ID: 6850590
[TBL] [Abstract][Full Text] [Related]
75. Fascin regulates chronic inflammation-related human colon carcinogenesis by inhibiting cell anoikis.
Kanda Y; Kawaguchi T; Kuramitsu Y; Kitagawa T; Kobayashi T; Takahashi N; Tazawa H; Habelhah H; Hamada J; Kobayashi M; Hirahata M; Onuma K; Osaki M; Nakamura K; Kitagawa T; Hosokawa M; Okada F
Proteomics; 2014 May; 14(9):1031-41. PubMed ID: 24574163
[TBL] [Abstract][Full Text] [Related]
76. Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-apoptotic protein Omi/HtrA2 into the cytoplasm.
Liu Z; Li H; Derouet M; Berezkin A; Sasazuki T; Shirasawa S; Rosen K
J Biol Chem; 2006 May; 281(21):14738-47. PubMed ID: 16461771
[TBL] [Abstract][Full Text] [Related]
77. Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
Corkery DP; Clarke LE; Gebremeskel S; Salsman J; Pinder J; Le Page C; Meunier L; Xu Z; Mes-Masson AM; Berman JN; Johnston B; Dellaire G
Oncogene; 2018 Jan; 37(2):174-184. PubMed ID: 28892043
[TBL] [Abstract][Full Text] [Related]
78. Autophagy Induction Results in Enhanced Anoikis Resistance in Models of Peritoneal Disease.
Chen JL; David J; Cook-Spaeth D; Casey S; Cohen D; Selvendiran K; Bekaii-Saab T; Hays JL
Mol Cancer Res; 2017 Jan; 15(1):26-34. PubMed ID: 27807188
[TBL] [Abstract][Full Text] [Related]
79. Antisense oligonucleotide to insulin-like growth factor II induces apoptosis in human ovarian cancer AO cell line.
Yin DL; Pu L; Pei G
Cell Res; 1998 Jun; 8(2):159-65. PubMed ID: 9669031
[TBL] [Abstract][Full Text] [Related]
80. URI is an oncogene amplified in ovarian cancer cells and is required for their survival.
Theurillat JP; Metzler SC; Henzi N; Djouder N; Helbling M; Zimmermann AK; Jacob F; Soltermann A; Caduff R; Heinzelmann-Schwarz V; Moch H; Krek W
Cancer Cell; 2011 Mar; 19(3):317-32. PubMed ID: 21397856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
